Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Colorado’s UCHealth system has extended the reach of “Livi,” an AI-powered virtual assistant it introduced early this year, from its website to patients’ smart speakers.
A large health data-sharing consortium based in Pittsburgh is bringing in Amazon Web Services to help drive research and product development around machine learning and cloud computing in numerous areas of healthcare.
China’s use of facial recognition software to encourage good citizenship has drawn international criticism, but now the country is turning to the technology for help with a worthy healthcare cause: finding elderly people with dementia who’ve lost their way.
Virtual reality isn’t quite there yet as a go-to screening tool for cognitive decline, but it can augment conventional methods. And senior citizens are open to its use for that purpose when it’s administered by their primary care doctor.
If geriatricians and primary care doctors could know which of their aging patients are at risk for Alzheimer’s disease, they could help these patients and their families prepare for what’s to come.
Researchers at the University of Delaware are developing a system of wearable video devices and AI analysis tools that, they hope, will help make roads and sidewalks friendlier to walkers, joggers, bicyclists and anyone else keeping fit outdoors.
Allowing natural language processing to pore over disparate data stored in electronic health records, researchers in Canada have shown the AI-based technology can reveal real-world experiences and outcomes of patients with stage III breast cancer.
Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.
The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals.
As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”
